This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
CANNABIS RESCHEDULING IS A VICTORY FOR PATIENTS BY PATIENTS Cannabis is being rescheduled because of its “currently accepted medical use in treatment in the United States.” 5 things Everyone Should Know About Cannabis Rescheduling: 1.
By Nikki Lawley & Oleg Maryasis, MS Medical cannabis patients in New York face unnecessary financial and accessibility barriers that limit their ability to receive the care they need.
Join Americans for Safe Access (ASA) for a Roundtable discussion on cannabis product recalls with key stakeholders to discuss the basics of recalls, how they work, what they mean for patients and consumer health, and why they signal a functioning cannabis regulatory system.
What could the implications be for patients on their medical cannabis journey? What does rescheduling cannabis mean for medical cannabis patients? The post What Could Rescheduling Mean for Medical Cannabis Patients? In the wake of this announcement, you may have a few questions. What does rescheduling actually mean?
John Bel Edwards has signed a series of bills into law greatly expanding patients ability to access medical cannabis products. ” Under the current law , doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer.
Lehigh Valley NORML, and medical cannabis patients from across Pennsylvania, will hold the second in a series of monthly protests at the Department of Health (PaDOH) headquarters on Forster St. “Patients First: Fixing Medical Marijuana in PA” will commence on Wednesday November 13, 2019 from 08:30 AM-5:00 PM.
A common challenge patients often experience when adult-use laws are adopted in their state is that legislative and regulatory improvements to medical cannabis programs are suspended while states pivot to organize adult-use models.
Additionally, a modification to the medical cannabis amendment we passed in 2014 opens the door for federal interference in state medical cannabis programs again (Section 531(b)) with double penalties. CLICK HERE to send a letter to your representatives telling them to prioritize patients!
Includes eliminating the requirement that patients register with the Board of Pharmacy after receiving their written certification from a registered practitioner. The post Virginia: Governor Youngkin Signs Legislation to Improve Medical Cannabis Program appeared first on NORML.
Under the plan, patients in the state’s medical access program will be able to purchase marijuana-infused gummies or other similar chewable products beginning on August 1, 2020. The post Minnesota: Regulators Okay Patients’ Access to Cannabis-Infused Edible Products appeared first on NORML.
The Sensible Enforcement Of Cannabis Act essentially would give peace of mind to lawmakers, regulators, 149,000+ workers, and the millions of patients and consumers who are dependent on the normalization of lawful marijuana markets. To date, these statewide regulatory programs are operating largely as voters and politicians intended.
After passing through the legislature with solid support and an enthusiastic Governor, this new law lays out a fairly restrictive program with a very long implementation period. Which unfortunately, means patients will continue to suffer in the meantime. Here is what you need to know about the new law…
The Decline of Medical Marijuana in Massachusetts: What It Means for Patients In recent years, Massachusetts, once a pioneer in cannabis reform, has seen its medical marijuana program gradually overshadowed by the booming recreational market. Let’s explore how this shift occurred and its implications for patients.
Representative Lynn Williams (D- HD 135) says, "Support for the issues around Maine's medical marijuana program crosses many lines: Republicans, Democrats, Independents, Libertarians and Greens; Downeast, Southern and Northern Maine; rural and urban; twenty-somethings, retirees and all in-between.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”
of votes in favor), which authorized the state’s department of health to create a medical cannabis program. Patients across the state should have equitable access to this treatment option and should not be burdened by localities that wrongly choose to opt out of the law. ASA strongly opposes both of these provisions.
Pennsylvania health officials have expanded the pool of patients eligible to receive medical cannabis access. John Fetterman called the changes “a truly powerful expansion” of the state’s program. An estimated 110,000 patients and over 1,600 physicians currently participate in the state-sponsored access program.
On Wednesday, September 25th, 2019, NORML testified at the DC Council Committee on Labor and Workforce Development in support of B23-0309 , the “Medical Marijuana ProgramPatient Employment Protection Amendment Act of 2019”, which seeks to expand workplace protections for medical cannabis patients in the District of Columbia.
The legalization of medical cannabis has covered most of the United States, offering patients an new alternative for their health. Today, there are more than six million registered medical cannabis patients but the safety and quality of the cannabis products they depend on have shocking gaps in how they are tested!
SB1719 allows “registered agents” for those patients physically unable to pick up or receive delivery of their medical cannabis, like those in hospice, assisted living facilities, and those who rely on home healthcare providers. Virginia NORML members meet with Senator Dave Marsden. “I am proud to be part of this effort.”
District council members have enacted legislation — Act Number A23-0114: The Medical Marijuana ProgramPatient Employment Protection Temporary Amendment Act — to protect qualified patients from workplace discrimination. ” To date, 15 states provide workplace protections for medical cannabis patients.
Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One.
Congress needs to hear from you about these priorities for patients: Pass the CJS Medical Cannabis Amendment without clawbacks to protect patients and providers.
Congress needs to hear from you about these priorities for patients: Pass the CJS Medical Cannabis Amendment without clawbacks to protect patients and providers.
Northam also signed Senate Bill 1015 , which states that no person may be arrested, prosecuted, or denied any right or privilege for participating in the state’s medical cannabis program. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
The focus of the subsequent three meetings was the examination of conditions under consideration for addition to the list of debilitating conditions that are qualifying for participation in the Medical Cannabis PatientProgram (MCPP).
The CRTA transfers authority over the Medical Cannabis Program from the Department of Health to the OCM, and in process overhauls some aspects of the program. The explicit language barring patients from “smoking” would be removed. development and hiring programs. development and hiring programs.
Every year, Americans for Safe Access spends months comparing every medical cannabis program in the United States with the purpose of analyzing what each program is doing well, where it is failing, and how the state program can improve to best serve the needs of patients.
.” Last session, the Governor vetoed legislation , House Bill 364, which sought to allow patients registered in the state’s medical cannabis access program the option to home-cultivate up to three cannabis plants.
The measure states that no person may be arrested, prosecuted, or denied any right or privilege for participating in the state’s medical cannabis oil program. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
Medical cannabis is essential and while we commend our state officials for declaring that centers will remain open during the state of emergency, we need to ensure our patients have uninterrupted access to their life saving medicine, especially during these uncertain times.
.” The CDC’s interest in alternative methods of chronic pain management may be of particular significance to many medical cannabis patients. According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5
At ASA, our goal is to ensure that every state has sensible cannabis policies that create safe and legal access for all patients. This means we believe that patients who medicate with cannabis should receive treatment equal to that of patients who medicate with any other drug. Many of which have been pediatric patients.
Northam also signed Senate Bill 1015 , which states that no person may be arrested, prosecuted, or denied any right or privilege for participating in the state’s medical cannabis program. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
Despite the fact that 36 states have reformed their laws to provide for safe and legal access to cannabis for qualifying patients, veterans living across these states still face a confusing system of federal and state laws regarding physician engagement and affordable access. For example, veterans who rely on the U.S.
Every year the ASA team and I spend a considerable amount of time formally comparing every medical cannabis program in the United States. In 2019 this meant assessing the medical cannabis programs of 47 states, the District of Columbia, and four territories.
Senate lawmakers approved legislation yesterday that seeks to regulate patients’ access to select medical cannabis products. Senators voted 22 to 11 in favor of SB 165 , which licenses dispensaries to provide qualified patients with non-herbal cannabis preparations, such as marijuana-infused tablets or pills.
The Illinois Department of Public Health (IDPH) and Division of Cannabis Regulation notified Medical Cannabis Patients, Caregivers, and Health Care Providers via email that a “new online registration portal for the Medical Cannabis PatientProgram and the Opioid Alternative PatientProgram will be coming soon.”
House lawmakers have overwhelmingly approved two bills to amend the state’s medical marijuana program in a manner that significantly expands patients’ access to cannabis products. The measure establishes regulations permitting the home delivery of medical cannabis products to registered patients.
Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”
"This is a setback for the growth and improvement of our existing program, but it will not be the last attempt to ease the barriers Arkansas’s medical patients encounter." The post Arkansas: Supreme Court Rules Against Medical Marijuana Ballot Measure appeared first on NORML.
A letter from ASA Founder & President The positive impacts of medical cannabis on patients and the healthcare systems that serve them are profound and far-reaching. Today, cannabis-based therapies provide relief to over 6 million Americans registered in medical cannabis programs in 38 states, D.C., and four of the five U.S.
Senators on Wednesday passed legislation to significantly expand the pool of patients eligible to qualify for medical cannabis access. ” Under the current law , doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer. .”
Oregon is one of the few but growing number of states that have both a medical cannabis program and an adult use (recreational) program, and users of cannabis medicine can be found in either group. A big thank you to Debbie for her time and to ASA for all that they do.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content